Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
iX Biopharma Ltd. ( (SG:42C) ) has issued an update.
iX Biopharma Ltd. has entered into a placement agreement with Oversea-Chinese Banking Corporation Limited to raise a minimum of S$5,000,000 through the issuance of new ordinary shares. This strategic move aims to enhance the company’s capital structure by offering shares that will constitute approximately 5.33% of its enlarged share capital. The placement is structured as an exempt offering in Singapore, targeting institutional and accredited investors, and is expected to bolster the company’s financial position, potentially impacting its market operations and investor relations positively.
More about iX Biopharma Ltd.
iX Biopharma Ltd. is a company incorporated in Singapore, operating in the biopharmaceutical industry. The company focuses on the development and commercialization of innovative therapies, with a particular emphasis on sublingual drug delivery systems.
Average Trading Volume: 8,678,119
Technical Sentiment Signal: Buy
Current Market Cap: S$83.55M
Learn more about 42C stock on TipRanks’ Stock Analysis page.